BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24222116)

  • 1. Therapeutic efficacy for hepatocellular carcinoma by boric acid-mediated boron neutron capture therapy in a rat model.
    Lin SY; Lin CJ; Liao JW; Peir JJ; Chen WL; Chi CW; Lin YC; Liu YM; Chou FI
    Anticancer Res; 2013 Nov; 33(11):4799-809. PubMed ID: 24222116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
    Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Efficacy and Radiobiological Effects of Boric Acid-mediated BNCT in a VX2 Multifocal Liver Tumor-bearing Rabbit Model.
    Hung YH; Lin YC; Lin YT; Shih GW; Liao JW; Chen KS; Liu HM; Chen YW; Chuang YJ; Yang CM; Peir JJ; Yang CH; Chou FI
    Anticancer Res; 2019 Oct; 39(10):5495-5504. PubMed ID: 31570443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of DNA Damage Responses After Boric Acid-mediated Boron Neutron Capture Therapy in Hepatocellular Carcinoma.
    Chen KH; Lai ZY; Li DY; Lin YC; Chou FI; Chuang YJ
    Anticancer Res; 2019 Dec; 39(12):6661-6671. PubMed ID: 31810931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suitability of boric acid as a boron drug for boron neutron capture therapy for hepatoma.
    Hung YH; Lin YC; Lin YT; Shih GW; Liao JW; Chen KS; Liu HM; Chen YW; Chuang YJ; Yang CM; Peir JJ; Yang CH; Chou FI
    Appl Radiat Isot; 2020 Oct; 164():109254. PubMed ID: 32554126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of using boric acid as a boron drug for boron neutron capture therapy for osteosarcoma.
    Hsu CF; Lin SY; Peir JJ; Liao JW; Lin YC; Chou FI
    Appl Radiat Isot; 2011 Dec; 69(12):1782-5. PubMed ID: 21420871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Tumor Microenvironment on Selective Uptake of Boric Acid in HepG2 Human Hepatoma Cells.
    Bai YC; Hsia YC; Lin YT; Chen KH; Chou FI; Yang CM; Chuang YJ
    Anticancer Res; 2017 Nov; 37(11):6347-6353. PubMed ID: 29061819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoradiographic and histopathological studies of boric acid-mediated BNCT in hepatic VX2 tumor-bearing rabbits: Specific boron retention and damage in tumor and tumor vessels.
    Yang CH; Lin YT; Hung YH; Liao JW; Peir JJ; Liu HM; Lin YL; Liu YM; Chen YW; Chuang KS; Chou FI
    Appl Radiat Isot; 2015 Dec; 106():176-80. PubMed ID: 26372198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First attempt of boron neutron capture therapy (BNCT) for hepatocellular carcinoma.
    Suzuki M; Sakurai Y; Hagiwara S; Masunaga S; Kinashi Y; Nagata K; Maruhashi A; Kudo M; Ono K
    Jpn J Clin Oncol; 2007 May; 37(5):376-81. PubMed ID: 17578894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility evaluation of neutron capture therapy for hepatocellular carcinoma using selective enhancement of boron accumulation in tumour with intra-arterial administration of boron-entrapped water-in-oil-in-water emulsion.
    Yanagie H; Kumada H; Nakamura T; Higashi S; Ikushima I; Morishita Y; Shinohara A; Fijihara M; Suzuki M; Sakurai Y; Sugiyama H; Kajiyama T; Nishimura R; Ono K; Nakajima J; Ono M; Eriguchi M; Takahashi H
    Appl Radiat Isot; 2011 Dec; 69(12):1854-7. PubMed ID: 21752660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Boron Neutron Capture Therapy (BNCT) on normal liver regeneration: towards a novel therapy for liver metastases.
    Cardoso JE; Trivillin VA; Heber EM; Nigg DW; Calzetta O; Blaumann H; Longhino J; Itoiz ME; Bumaschny E; Pozzi E; Schwint AE
    Int J Radiat Biol; 2007 Oct; 83(10):699-706. PubMed ID: 17729164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective boron delivery by intra-arterial injection of BSH-WOW emulsion in hepatic cancer model for neutron capture therapy.
    Yanagie H; Dewi N; Higashi S; Ikushima I; Seguchi K; Mizumachi R; Murata Y; Morishita Y; Shinohara A; Mikado S; Yasuda N; Fujihara M; Sakurai Y; Mouri K; Yanagawa M; Iizuka T; Suzuki M; Sakurai Y; Masunaga SI; Tanaka H; Matsukawa T; Yokoyama K; Fujino T; Ogura K; Nonaka Y; Sugiyama H; Kajiyama T; Yui S; Nishimura R; Ono K; Takamoto S; Nakajima J; Ono M; Eriguchi M; Hasumi K; Takahashi H
    Br J Radiol; 2017 Jun; 90(1074):20170004. PubMed ID: 28406315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boron neutron capture therapy (BNCT) for the treatment of liver metastases: biodistribution studies of boron compounds in an experimental model.
    Garabalino MA; Monti Hughes A; Molinari AJ; Heber EM; Pozzi EC; Cardoso JE; Colombo LL; Nievas S; Nigg DW; Aromando RF; Itoiz ME; Trivillin VA; Schwint AE
    Radiat Environ Biophys; 2011 Mar; 50(1):199-207. PubMed ID: 21132507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology.
    Trivillin VA; Heber EM; Nigg DW; Itoiz ME; Calzetta O; Blaumann H; Longhino J; Schwint AE
    Radiat Res; 2006 Aug; 166(2):387-96. PubMed ID: 16881740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro evaluation of the phenylboric acid derivative entrapped lipiodol in boron neutron capture therapy for hepatoma.
    Chou FI; Chung HP; Shieh MS; Huang CW; Chung RJ; Liu HM; Yang JY; Chi CW; Lin YC; Lui WY; Kai JJ
    Anticancer Res; 2003; 23(5A):3955-63. PubMed ID: 14666703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asialoglycoprotein receptor targeted micelles containing carborane clusters for effective boron neutron capture therapy of hepatocellular carcinoma.
    Zhang T; Li G; Li S; Wang Z; He D; Wang Y; Zhang J; Li J; Bai Z; Zhang Q; Liu B; Zhao Q; Liu Y; Zhang H
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110397. PubMed ID: 31357127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
    Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Efficacy and Radiobiological Effects of Boric-Acid-Mediated BNCT in an Osteosarcoma-Bearing SD Rat Model.
    Hsu CF; Liu HM; Peir JJ; Liao JW; Chen KS; Chen YW; Chuang YJ; Chou FI
    Life (Basel); 2023 Feb; 13(2):. PubMed ID: 36836871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward a clinical application of ex situ boron neutron capture therapy for lung tumors at the RA-3 reactor in Argentina.
    Farías RO; Garabalino MA; Ferraris S; Santa María J; Rovati O; Lange F; Trivillin VA; Monti Hughes A; Pozzi EC; Thorp SI; Curotto P; Miller ME; Santa Cruz GA; Bortolussi S; Altieri S; Portu AM; Saint Martin G; Schwint AE; González SJ
    Med Phys; 2015 Jul; 42(7):4161-73. PubMed ID: 26133616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine.
    Kreimann EL; Itoiz ME; Dagrosa A; Garavaglia R; Farías S; Batistoni D; Schwint AE
    Cancer Res; 2001 Dec; 61(24):8775-81. PubMed ID: 11751398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.